Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 26, 2021

SELL
$282.99 - $369.05 $2.18 Million - $2.85 Million
-7,721 Closed
0 $0
Q2 2021

Jul 28, 2021

SELL
$259.0 - $414.71 $137,270 - $219,796
-530 Reduced 6.42%
7,721 $2.67 Million
Q1 2021

May 03, 2021

SELL
$242.95 - $284.63 $15,791 - $18,500
-65 Reduced 0.78%
8,251 $2.31 Million
Q4 2020

Jan 25, 2021

SELL
$236.26 - $355.63 $1.79 Million - $2.69 Million
-7,572 Reduced 47.66%
8,316 $2.04 Million
Q3 2020

Oct 30, 2020

SELL
$264.77 - $305.71 $60,367 - $69,701
-228 Reduced 1.41%
15,888 $4.51 Million
Q2 2020

Aug 10, 2020

SELL
$258.66 - $342.55 $95,445 - $126,400
-369 Reduced 2.24%
16,116 $4.31 Million
Q1 2020

Apr 20, 2020

SELL
$268.85 - $341.04 $6,721 - $8,526
-25 Reduced 0.15%
16,485 $5.22 Million
Q4 2019

Feb 03, 2020

SELL
$220.06 - $304.07 $110,030 - $152,035
-500 Reduced 2.94%
16,510 $4.9 Million
Q3 2019

Oct 29, 2019

SELL
$217.44 - $243.88 $48,271 - $54,141
-222 Reduced 1.29%
17,010 $3.96 Million
Q2 2019

Jul 31, 2019

SELL
$219.29 - $241.72 $161,178 - $177,664
-735 Reduced 4.09%
17,232 $4.03 Million
Q1 2019

May 07, 2019

BUY
$216.71 - $338.96 $48,543 - $75,927
224 Added 1.26%
17,967 $4.25 Million
Q4 2018

Jan 29, 2019

BUY
$278.5 - $352.75 $25,343 - $32,100
91 Added 0.52%
17,743 $5.34 Million
Q3 2018

Oct 17, 2018

SELL
$293.51 - $383.83 $32,873 - $42,988
-112 Reduced 0.63%
17,652 $6.24 Million
Q2 2018

Jul 31, 2018

BUY
$257.52 - $306.91 $224,557 - $267,625
872 Added 5.16%
17,764 $5.16 Million
Q1 2018

Apr 17, 2018

BUY
$260.13 - $367.91 $174,287 - $246,499
670 Added 4.13%
16,892 $4.63 Million
Q4 2017

Jan 22, 2018

BUY
$307.64 - $344.58 $13,843 - $15,506
45 Added 0.28%
16,222 $5.17 Million
Q3 2017

Oct 31, 2017

BUY
$281.15 - $329.69 $4.55 Million - $5.33 Million
16,177
16,177 $5.07 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Hendershot Investments Inc. Portfolio

Follow Hendershot Investments Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hendershot Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hendershot Investments Inc. with notifications on news.